Avidity Biosciences remains a Strong Buy for me, driven by Del-zota's promising data in targeting Duchenne Muscular Dystrophy ...

Veronika Skvortsova, head of Russia's Federal Medical and Biological Agency (FMBA), announced last week that the country's ...

Revolution Medicines, Inc. shares surged on strong Phase 1 data for daraxonrasib in metastatic pancreatic cancer. Click here ...

Revolution Medicines (RVMD) on Wednesday announced clinical updates from its daraxonrasib Phase 1 clinical trials. The data focuses on new ...

Investigators have used base editing to create a treatment for multisystemic smooth muscle dysfunction syndrome, which has ...

These encouraging clinical results support the company’s plans to initiate RASolute 303, a global, randomized Phase 3 trial in patients with 1L metastatic PDAC, in the fourth quarter of 2025. The ...

Researchers at Mass General Brigham in Boston have designed a custom gene editing technique that corrected the mutation ...

Traces of DNA in the environment can tell us how species' ranges are changing as a result of increasing sea temperatures.

Mitochondria act as energy factories in cells and have their own, separate DNA. Mutations to mitochondrial DNA (mtDNA) have been observed in cancer, but it has been unclear how these changes might ...

Multisystemic smooth muscle dysfunction syndrome (MSMDS) is a rare condition associated with stroke, aortic dissection ...